Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04368442
Status:
UNKNOWN
Last Update Posted:
2020-04-29
First Post:
2020-04-23
Brief Title:
Cohort Study of Patients With HER2-negative MBC and BRCA 12 Pathogenic Mutation
Sponsor:
Organization:
Samsung Medical Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
3 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
1 DNA form the peripheral blood
2 optional Extracted DNA from the FFPE
Enrollment Count:
583
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 64342 |
Who Masked List: